|
JP3867171B2
(ja)
|
1994-04-22 |
2007-01-10 |
アステラス製薬株式会社 |
結腸特異的薬物放出システム
|
|
EP1092434B1
(en)
*
|
1995-09-21 |
2004-03-24 |
Pharma Pass II LLC |
Novel composition containing lansoprazole and process for its preparation
|
|
US6231888B1
(en)
*
|
1996-01-18 |
2001-05-15 |
Perio Products Ltd. |
Local delivery of non steroidal anti inflammatory drugs (NSAIDS) to the colon as a treatment for colonic polyps
|
|
WO1998005310A1
(fr)
*
|
1996-08-02 |
1998-02-12 |
Hisamitsu Pharmaceutical Co., Inc. |
Gelules destinees a des preparations orales et preparations de gelules destinees a une administration orale
|
|
SE9604751D0
(sv)
*
|
1996-12-20 |
1996-12-20 |
Astra Ab |
New therapy
|
|
GB9720797D0
(en)
*
|
1997-09-30 |
1997-12-03 |
Rhodes John |
Pharmaceutical composition for the treatment of inflammatory bowel disease and irritable bowel syndrome
|
|
TR200000944T2
(tr)
*
|
1997-10-09 |
2000-11-21 |
Perio Products Ltd. |
Geciktirmeli tam çözünümlü mide-bağırsak bölgesi ilaç verme sistemi.
|
|
US6350470B1
(en)
*
|
1998-04-29 |
2002-02-26 |
Cima Labs Inc. |
Effervescent drug delivery system for oral administration
|
|
EP1079810B1
(en)
*
|
1998-04-22 |
2004-06-16 |
Glycologic Limited |
Orally administrable compositions comprising cation cross-linked polysaccharide and a polymer digestible in the lower gastrointestinal tract
|
|
US7022683B1
(en)
|
1998-05-13 |
2006-04-04 |
Carrington Laboratories, Inc. |
Pharmacological compositions comprising pectins having high molecular weights and low degrees of methoxylation
|
|
CA2587022A1
(en)
|
1998-05-18 |
1999-11-25 |
Takeda Pharmaceutical Company Limited |
Orally disintegrable tablets
|
|
PT1733735T
(pt)
|
1998-05-22 |
2017-06-16 |
Ottawa Hospital Res Inst |
Métodos e produtos para induzir imunidade mucosal
|
|
TW585786B
(en)
|
1998-07-28 |
2004-05-01 |
Takeda Chemical Industries Ltd |
Lansoprazole-containing rapidly disintegrable solid pharmaceutical composition
|
|
US7041313B1
(en)
*
|
1998-08-12 |
2006-05-09 |
Altana Pharma Ag |
Oral administration form for pyridin-2-ylmethylsulfinyl-1H-benzimidazoles
|
|
US6387410B1
(en)
|
1998-09-10 |
2002-05-14 |
Norton Healthcare Ltd |
Anti-inflammatory pharmaceutical formulations
|
|
US6514525B2
(en)
|
1998-09-10 |
2003-02-04 |
Norton Healthcare Ltd |
Anti-inflammatory pharmaceutical formulations
|
|
US6645192B2
(en)
*
|
1998-09-30 |
2003-11-11 |
Ivy Animal Health, Inc. |
Pellet implant system for immediate and delayed release of antiparasitic drug
|
|
US6531152B1
(en)
*
|
1998-09-30 |
2003-03-11 |
Dexcel Pharma Technologies Ltd. |
Immediate release gastrointestinal drug delivery system
|
|
US20090149479A1
(en)
*
|
1998-11-02 |
2009-06-11 |
Elan Pharma International Limited |
Dosing regimen
|
|
EP1126826B3
(en)
*
|
1998-11-02 |
2019-05-15 |
Alkermes Pharma Ireland Limited |
Multiparticulate modified release composition of methylphenidate
|
|
US20060240105A1
(en)
*
|
1998-11-02 |
2006-10-26 |
Elan Corporation, Plc |
Multiparticulate modified release composition
|
|
AR023699A1
(es)
*
|
1998-11-12 |
2002-09-04 |
Smithkline Beecham Corp |
Una composicion farmaceutica que comprende un estabilizador de insulina y un procedimiento para preparar una composicion farmaceutica
|
|
SA99191255B1
(ar)
|
1998-11-30 |
2006-11-25 |
جي دي سيرل اند كو |
مركبات سيليكوكسيب celecoxib
|
|
US6432448B1
(en)
*
|
1999-02-08 |
2002-08-13 |
Fmc Corporation |
Edible coating composition
|
|
US6723342B1
(en)
|
1999-02-08 |
2004-04-20 |
Fmc Corporation |
Edible coating composition
|
|
US6351665B1
(en)
|
1999-05-07 |
2002-02-26 |
Kenneth L Koch |
Method and apparatus for evaluating myoelectric signals and identifying artifact
|
|
US6632451B2
(en)
*
|
1999-06-04 |
2003-10-14 |
Dexcel Pharma Technologies Ltd. |
Delayed total release two pulse gastrointestinal drug delivery system
|
|
US6972132B1
(en)
|
1999-06-09 |
2005-12-06 |
Mochida Pharamceutical Co., Ltd. |
System for release in lower digestive tract
|
|
US8895064B2
(en)
|
1999-06-14 |
2014-11-25 |
Cosmo Technologies Limited |
Controlled release and taste masking oral pharmaceutical composition
|
|
JP4790950B2
(ja)
*
|
1999-06-14 |
2011-10-12 |
コスモ・テクノロジーズ・リミテッド |
制御放出および味感遮蔽経口医薬組成物
|
|
SE9902386D0
(sv)
*
|
1999-06-22 |
1999-06-22 |
Astra Ab |
New formulation
|
|
US20040258750A1
(en)
*
|
1999-06-28 |
2004-12-23 |
Gerard Alaux |
Timed dual release dosage forms comprising a short acting hypnotic or a salt thereof
|
|
EP1064938A1
(en)
*
|
1999-06-28 |
2001-01-03 |
Sanofi-Synthelabo |
Pharmaceutical dosage forms for controlled release producing at least a timed pulse
|
|
ES2288152T3
(es)
*
|
1999-08-09 |
2008-01-01 |
Dainippon Sumitomo Pharma Co., Ltd. |
Preparaciones solidas que contienen polvo de quitosano y procedimiento de produccion asociado.
|
|
EP2295043A1
(en)
|
1999-10-29 |
2011-03-16 |
Euro-Celtique S.A. |
Controlled release hydrocodone formulations
|
|
US10179130B2
(en)
|
1999-10-29 |
2019-01-15 |
Purdue Pharma L.P. |
Controlled release hydrocodone formulations
|
|
US6500462B1
(en)
|
1999-10-29 |
2002-12-31 |
Fmc Corporation |
Edible MCC/PGA coating composition
|
|
IL133196A0
(en)
*
|
1999-11-29 |
2001-03-19 |
Yissum Res Dev Co |
Gastroretentive controlled release pharmaceutical dosage forms
|
|
US7771746B2
(en)
*
|
1999-12-03 |
2010-08-10 |
Polichem Sa |
Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof
|
|
DE19961897A1
(de)
*
|
1999-12-20 |
2001-06-28 |
Basf Ag |
Verwendung eines Filmüberzuges als geschmacksmaskierendes Coating von pharmazeutischen Darreichungsformen
|
|
DK1242055T3
(da)
*
|
1999-12-23 |
2008-07-21 |
Pfizer Prod Inc |
Hydrogelstyret doseringsform til lægemidler
|
|
WO2001047498A2
(en)
|
1999-12-23 |
2001-07-05 |
Pfizer Products Inc. |
Hydrogel-driven layered drug dosage form comprising sertraline
|
|
US6451345B1
(en)
*
|
2000-01-20 |
2002-09-17 |
Eurand Pharmaceuticals Ltd. |
Functional coating of linezolid microcapsules for taste-masking and associated formulation for oral administration
|
|
EP1251832B1
(en)
*
|
2000-02-04 |
2006-09-27 |
Depomed, Inc. |
Shell-and-core dosage form approaching zero-order drug release
|
|
IN192159B
(es)
*
|
2000-05-15 |
2004-02-28 |
Ranbaxy Lab Ltd |
|
|
CN1141974C
(zh)
*
|
2000-06-07 |
2004-03-17 |
张昊 |
结肠定位释放的口服生物制剂
|
|
CN1285333C
(zh)
*
|
2000-06-07 |
2006-11-22 |
张昊 |
结肠定位释放的口服制剂及其制备方法
|
|
IL137431A0
(en)
|
2000-07-20 |
2001-07-24 |
Slo Flo Ltd |
A new slow release device for controlled delivery of liquid material
|
|
KR100411195B1
(ko)
*
|
2000-09-26 |
2003-12-18 |
한국화학연구원 |
케토롤락 트로메타민이 함유된 서방형 펠렛
|
|
CN100518827C
(zh)
|
2000-10-30 |
2009-07-29 |
欧罗赛铁克股份有限公司 |
控释氢可酮制剂
|
|
US6932861B2
(en)
*
|
2000-11-28 |
2005-08-23 |
Fmc Corporation |
Edible PGA coating composition
|
|
WO2002043694A2
(en)
|
2000-11-28 |
2002-06-06 |
Fmc Corporation |
Edible pga(propylene glycol alginate) coating composition
|
|
US7494669B2
(en)
|
2001-02-28 |
2009-02-24 |
Carrington Laboratories, Inc. |
Delivery of physiological agents with in-situ gels comprising anionic polysaccharides
|
|
US6777000B2
(en)
|
2001-02-28 |
2004-08-17 |
Carrington Laboratories, Inc. |
In-situ gel formation of pectin
|
|
US7316819B2
(en)
*
|
2001-03-08 |
2008-01-08 |
Unigene Laboratories, Inc. |
Oral peptide pharmaceutical dosage form and method of production
|
|
WO2002094173A2
(en)
*
|
2001-05-22 |
2002-11-28 |
Euro-Celtique |
Tamper resistant oral dosage form
|
|
WO2003002100A1
(en)
*
|
2001-06-26 |
2003-01-09 |
Farrell John J |
Tamper-proof narcotic delivery system
|
|
US20030091630A1
(en)
*
|
2001-10-25 |
2003-05-15 |
Jenny Louie-Helm |
Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data
|
|
US20030104052A1
(en)
*
|
2001-10-25 |
2003-06-05 |
Bret Berner |
Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
|
|
CA2409552A1
(en)
|
2001-10-25 |
2003-04-25 |
Depomed, Inc. |
Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
|
|
US20030152622A1
(en)
*
|
2001-10-25 |
2003-08-14 |
Jenny Louie-Helm |
Formulation of an erodible, gastric retentive oral diuretic
|
|
US7045549B2
(en)
|
2001-11-08 |
2006-05-16 |
The Board Of Trustees Of The Leland Stanford Jr. University |
Treatment of symptoms associated with irritable bowel syndrome
|
|
US7550156B2
(en)
|
2001-11-23 |
2009-06-23 |
Rohm And Haas Company |
Optimised pellet formulations
|
|
MXPA04006163A
(es)
*
|
2001-12-20 |
2004-11-01 |
Pharmacia Corp |
Formas de dosis de liberacion sostenida del orden-cero y metodo de fabricacion de las mismas.
|
|
IL162857A0
(en)
*
|
2002-01-15 |
2005-11-20 |
Bio Life Science Forschungs & Entwicklungsgesellschaft Mbh |
Oral vaccination
|
|
EP1327450B1
(de)
*
|
2002-01-15 |
2007-08-15 |
Bio Life Science Forschungs- und Entwicklungsges.m.b.H. |
Orale Vakzinierung mit nackten Tumor-Antigen-Mimotopen
|
|
US20040071780A1
(en)
*
|
2002-01-16 |
2004-04-15 |
Lillard James W. |
PACE-A microspheres for delivery of antigens
|
|
US20060073204A1
(en)
*
|
2002-03-05 |
2006-04-06 |
Sandhya Goyal |
Modified release oral pharmaceutical composition
|
|
US20040156844A1
(en)
*
|
2002-05-22 |
2004-08-12 |
Curtis Wright |
Tamper resistant oral dosage form
|
|
US6986901B2
(en)
|
2002-07-15 |
2006-01-17 |
Warner-Lambert Company Llc |
Gastrointestinal compositions
|
|
US7985422B2
(en)
*
|
2002-08-05 |
2011-07-26 |
Torrent Pharmaceuticals Limited |
Dosage form
|
|
FR2843872B1
(fr)
|
2002-08-29 |
2005-08-19 |
C T M Ct De Transfert Des Micr |
Dispositif de localisation equipant une capsule intestinale
|
|
US20040062778A1
(en)
*
|
2002-09-26 |
2004-04-01 |
Adi Shefer |
Surface dissolution and/or bulk erosion controlled release compositions and devices
|
|
US6703044B1
(en)
*
|
2002-10-25 |
2004-03-09 |
Dexcel Pharma Tech, Ltd |
Venlafaxine formulations
|
|
JP2006507298A
(ja)
*
|
2002-10-30 |
2006-03-02 |
ファルマシア コーポレーション |
経口持続放出型錠剤、ならびにその製造法および使用法
|
|
US9561182B2
(en)
|
2003-08-22 |
2017-02-07 |
Cure Pharmaceutical Corporation |
Edible films for administration of medicaments to animals, methods for their manufacture and methods for their use for the treatment of animals
|
|
CN1322865C
(zh)
*
|
2002-11-14 |
2007-06-27 |
北京东方凯恩医药科技有限公司 |
用于治疗菌痢的口服结肠定位给药组合物
|
|
US20040096497A1
(en)
*
|
2002-11-19 |
2004-05-20 |
Ponder Garratt W. |
Methods of providing controlled-release pharmaceutical compositions and controlled-release pharmaceutical compositions
|
|
US8519008B2
(en)
|
2003-01-22 |
2013-08-27 |
Purina Animal Nutrition Llc |
Method and composition for improving the health of young monogastric mammals
|
|
RU2375048C2
(ru)
*
|
2003-07-17 |
2009-12-10 |
Д-Р Редди'С Лабораторис Инк. |
Фармацевтическая композиция с набухающим покрытием
|
|
US20050147663A1
(en)
*
|
2003-07-17 |
2005-07-07 |
Mohan Mailatur S. |
Method of treatment for improved bioavailability
|
|
US7737133B2
(en)
*
|
2003-09-03 |
2010-06-15 |
Agi Therapeutics Ltd. |
Formulations and methods of treating inflammatory bowel disease
|
|
US7825106B2
(en)
|
2003-09-03 |
2010-11-02 |
Agi Therapeutics Ltd. |
Modified release formulations and methods of treating inflammatory bowel disease
|
|
EA200600598A1
(ru)
*
|
2003-09-19 |
2006-08-25 |
Пенвест Фармасьютикалз Ко. |
Лекарственные формы замедленного высвобождения
|
|
US7314938B2
(en)
|
2003-11-05 |
2008-01-01 |
Sunesis Pharmaceuticals, Inc. |
Modulators of cellular adhesion
|
|
EP1691789B1
(en)
|
2003-11-25 |
2017-12-20 |
SmithKline Beecham (Cork) Limited |
Carvedilol free base, salts, anhydrous forms or solvate thereof, corresponding pharmaceutical compositions, controlled release formulations, and treatment or delivery methods
|
|
WO2005076824A2
(en)
*
|
2004-02-03 |
2005-08-25 |
The Regents Of The University Of California |
Methods of treating irritable bowel syndrome
|
|
AU2005247195A1
(en)
*
|
2004-05-27 |
2005-12-08 |
Dexcel Pharma Technologies Ltd |
Localized controlled absorption of statins in the gastrointestinal tract for achieving high blood levels of statins
|
|
EP1817010A4
(en)
*
|
2004-11-22 |
2009-06-17 |
Dexcel Pharma Technologies Ltd |
CONTROLLED ABSORPTION OF STATINS IN THE INTESTINE
|
|
AU2005305460B2
(en)
*
|
2004-11-22 |
2011-04-21 |
Dexcel Pharma Technologies Ltd. |
Stable atorvastatin formulations
|
|
FR2878159B1
(fr)
*
|
2004-11-24 |
2008-10-17 |
Flamel Technologies Sa |
Medicament oral a liberation modifiee d'au moins un principe actif sous forme multimicrocapsulaire
|
|
US20060121112A1
(en)
*
|
2004-12-08 |
2006-06-08 |
Elan Corporation, Plc |
Topiramate pharmaceutical composition
|
|
US20060159753A1
(en)
*
|
2004-12-27 |
2006-07-20 |
Eisai Co. Ltd. |
Matrix type sustained-release preparation containing basic drug or salt thereof
|
|
WO2006070930A1
(en)
|
2004-12-27 |
2006-07-06 |
Eisai R & D Management Co., Ltd. |
Method for stabilizing anti-dementia drug
|
|
JP2008531755A
(ja)
*
|
2005-01-05 |
2008-08-14 |
ボード オブ リージェンツ， ザ ユニバーシティ オブ テキサス システム |
二重画像化および放射線化学療法のためのコンジュゲート：組成物、製造および適応
|
|
ES2522895T3
(es)
|
2005-03-03 |
2014-11-19 |
Alfa Wassermann S.P.A. |
Nuevas formas polimorfas de rifaximina, procedimientos para su producción y uso de las mismas en preparados medicinales
|
|
ITBO20050123A1
(it)
*
|
2005-03-07 |
2005-06-06 |
Alfa Wassermann Spa |
Formulazioni farmaceutiche gastroresistenti contenenti rifaximina
|
|
CA2601800C
(en)
*
|
2005-03-14 |
2013-12-03 |
Nitin Bhalachandra Dharmadhikari |
Oral drug delivery system
|
|
US20080260818A1
(en)
*
|
2005-03-28 |
2008-10-23 |
Dexcel Pharma Technologies Ltd. |
Controlled Absorption of Statins in the Intestine
|
|
US20080069870A1
(en)
*
|
2005-04-12 |
2008-03-20 |
Elan Corporation Pic |
Controlled Release Compositions Comprising a Cephalosporin for the Treatment of a Bacterial Infection
|
|
US8168655B2
(en)
*
|
2005-05-17 |
2012-05-01 |
Sarcode Bioscience Inc. |
Compositions and methods for treatment of eye disorders
|
|
US20060280795A1
(en)
*
|
2005-06-08 |
2006-12-14 |
Dexcel Pharma Technologies, Ltd. |
Specific time-delayed burst profile delivery system
|
|
US8778395B2
(en)
*
|
2005-08-11 |
2014-07-15 |
Andrx Labs, Llc |
Diltiazem controlled release formulation and method of manufacture
|
|
US20070082027A1
(en)
*
|
2005-10-07 |
2007-04-12 |
Aimutis William R Jr |
Compositions and methods for reducing food intake and controlling weight
|
|
US20070082029A1
(en)
*
|
2005-10-07 |
2007-04-12 |
Aimutis William R |
Fiber satiety compositions
|
|
US8497258B2
(en)
|
2005-11-12 |
2013-07-30 |
The Regents Of The University Of California |
Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
|
|
EP2037882B1
(en)
|
2006-06-28 |
2014-12-10 |
SurModics, Inc. |
Combination degradable and non-degradable matrices for active agent delivery
|
|
UA96457C2
(ru)
|
2006-08-03 |
2011-11-10 |
Нитек Фарма Аг |
Лечение ревматоидного артрита глюкокортикоидами с отсроченным высвобождением
|
|
US8889184B2
(en)
*
|
2006-09-07 |
2014-11-18 |
Losan Pharma Gmbh |
Particulate form of a pharmaceutical composition which is easy to swallow
|
|
US20100055173A1
(en)
*
|
2006-10-10 |
2010-03-04 |
Adel Penhasi |
Release of statins in the intestine
|
|
US8273376B2
(en)
|
2006-11-17 |
2012-09-25 |
Da Volterra |
Colonic delivery of metallo-dependent enzymes
|
|
CA2678131A1
(en)
*
|
2006-11-17 |
2008-05-22 |
Antoine Andremont |
Colonic delivery using zn/pectin beads with a eudragit coating.
|
|
US20080260823A1
(en)
*
|
2007-04-20 |
2008-10-23 |
Sciele Pharma, Inc. |
Orally disintegrating tablet comprising glycopyrrolate for treating sialorrhea
|
|
US20090036414A1
(en)
*
|
2007-08-02 |
2009-02-05 |
Mutual Pharmaceutical Company, Inc. |
Mesalamine Formulations
|
|
WO2009037264A2
(en)
*
|
2007-09-17 |
2009-03-26 |
Da Volterra |
Colonic delivery of antimicrobial agents
|
|
EP3167886B1
(en)
|
2007-10-19 |
2020-08-05 |
Novartis AG |
Compositions and methods for treatment of macular edema
|
|
US20100216754A1
(en)
*
|
2007-11-13 |
2010-08-26 |
Meritage Pharma, Inc. |
Compositions for the treatment of inflammation of the gastrointestinal tract
|
|
US8865692B2
(en)
|
2007-11-13 |
2014-10-21 |
Meritage Pharma, Inc |
Compositions for the treatment of gastrointestinal inflammation
|
|
AU2008321396A1
(en)
|
2007-11-13 |
2009-05-22 |
Meritage Pharma, Inc. |
Compositions for the treatment of inflammation of the gastrointestinal tract
|
|
US20090169622A1
(en)
*
|
2007-12-27 |
2009-07-02 |
Roxane Laboratories, Inc. |
Delayed-release oral pharmaceutical composition for treatment of colonic disorders
|
|
US8080562B2
(en)
*
|
2008-04-15 |
2011-12-20 |
Sarcode Bioscience Inc. |
Crystalline pharmaceutical and methods of preparation and use thereof
|
|
ES2425762T3
(es)
*
|
2008-10-27 |
2013-10-17 |
Roquette Freres |
Polímero insoluble en agua: revestimientos de película a base de derivados de almidón modificado para la liberación dirigida al colon
|
|
NZ582836A
(en)
*
|
2009-01-30 |
2011-06-30 |
Nitec Pharma Ag |
Delayed-release glucocorticoid treatment of rheumatoid arthritis by improving signs and symptoms, showing major or complete clinical response and by preventing from joint damage
|
|
US8945615B2
(en)
*
|
2009-02-17 |
2015-02-03 |
Mylan Pharmaceuticals Inc. |
Controlled release budesonide minitablets
|
|
US8945616B2
(en)
*
|
2009-02-17 |
2015-02-03 |
Mylan Pharmaceuticals Inc. |
Controlled release budesonide minitablets
|
|
WO2010103119A1
(en)
*
|
2009-03-13 |
2010-09-16 |
Da Volterra |
Compositions and methods for elimination of gram-negative bacteria
|
|
US20110097401A1
(en)
*
|
2009-06-12 |
2011-04-28 |
Meritage Pharma, Inc. |
Methods for treating gastrointestinal disorders
|
|
US8378105B2
(en)
*
|
2009-10-21 |
2013-02-19 |
Sarcode Bioscience Inc. |
Crystalline pharmaceutical and methods of preparation and use thereof
|
|
IT1398550B1
(it)
|
2010-03-05 |
2013-03-01 |
Alfa Wassermann Spa |
Formulazioni comprendenti rifaximina utili per ottenere un effetto prolungato nel tempo
|
|
CA2802994A1
(en)
|
2010-06-17 |
2011-12-22 |
The United States Of America As Represented By The Secretary, National I Nstitutes Of Health |
Compositions and methods for treating inflammatory conditions
|
|
US8911780B2
(en)
|
2011-02-11 |
2014-12-16 |
Zx Pharma, Llc |
Multiparticulate L-menthol formulations and related methods
|
|
RU2590979C2
(ru)
|
2011-02-11 |
2016-07-10 |
ЗедЭкс ФАРМА, ЭлЭлСи |
Составы l-ментола, состоящие из множества частиц, и связанные с ними способы
|
|
US8808736B2
(en)
|
2011-02-11 |
2014-08-19 |
Zx Pharma, Llc |
Enteric coated multiparticulate controlled release peppermint oil composition and related methods
|
|
SG10201606751XA
(en)
*
|
2011-05-13 |
2016-10-28 |
Eb Ip Hybritabs B V |
Drug Delivery System
|
|
ITBO20110461A1
(it)
|
2011-07-29 |
2013-01-30 |
Alfa Wassermann Spa |
Composizioni farmaceutiche comprendenti rifaximina, processi per la loro preparazione e loro uso nel trattamento di infezioni vaginali.
|
|
US10154964B2
(en)
|
2011-09-07 |
2018-12-18 |
Cosmo Technologies Limited |
Controlled release and taste masking oral pharmaceutical composition
|
|
ITBO20120368A1
(it)
|
2012-07-06 |
2014-01-07 |
Alfa Wassermann Spa |
Composizioni comprendenti rifaximina e amminoacidi, cristalli di rifaximina derivanti da tali composizioni e loro uso.
|
|
CN104797574B
(zh)
|
2012-07-25 |
2019-11-22 |
原生质生物科学股份有限公司 |
Lfa-1抑制剂及其多晶型物
|
|
US20140066837A1
(en)
|
2012-07-26 |
2014-03-06 |
Ronald L. Moy |
Skin care compositions and methods
|
|
US9289418B2
(en)
|
2013-03-15 |
2016-03-22 |
Cedars-Sinai Medical Center |
Methods of diagnosis, selection, and treatment of diseases and conditions caused by or associated with methanogens
|
|
CN105208861A
(zh)
|
2013-03-15 |
2015-12-30 |
雪松-西奈医学中心 |
由产甲烷菌引起或与之相关的疾病和病状的诊断、选择和治疗方法
|
|
SG11201507777TA
(en)
*
|
2013-03-26 |
2015-10-29 |
Lipid Therapeutics Gmbh |
Pharmaceutical formulation comprising phosphatidylcholine for the treatment of ulcerative colitis
|
|
EP2872123B1
(en)
|
2013-04-23 |
2017-01-04 |
Zx Pharma, Llc |
Enteric coated multiparticulate controlled release peppermint oil composition and related methods
|
|
HUE050054T2
(hu)
|
2014-05-12 |
2020-11-30 |
Alfasigma Spa |
DEGME-vel szolvatált rifaximin tau kristályos formájának elõállítása és alkalmazása
|
|
BR112016028957B1
(pt)
|
2014-06-11 |
2021-12-14 |
The Brigham And Women's Hospital, Inc. |
Estrutura de residência gástrica
|
|
US20170266112A1
(en)
|
2014-06-11 |
2017-09-21 |
Massachusetts Institute Of Technology |
Residence structures and related methods
|
|
MX2017001971A
(es)
|
2014-08-13 |
2017-09-15 |
Cedars Sinai Medical Center |
Composiciones antimetanogenicas y sus usos.
|
|
US20160158174A1
(en)
*
|
2014-12-09 |
2016-06-09 |
Intercontinental Great Brands Llc |
Enteric-Coated Functional Food Ingredients And Methods For Making The Enteric-Coated Functional Food Ingredients
|
|
WO2016161085A1
(en)
|
2015-04-01 |
2016-10-06 |
Cedars-Sinai Medical Center |
Anti-methanogenic lovastatin analogs or derivatives and uses thereof
|
|
US10953208B2
(en)
|
2015-05-01 |
2021-03-23 |
Massachusetts Institute Of Technology |
Triggerable shape memory induction devices
|
|
AU2016342374B2
(en)
|
2015-10-23 |
2022-08-04 |
Lyndra Therapeutics, Inc. |
Gastric residence systems for sustained release of therapeutic agents and methods of use thereof
|
|
JP7030052B2
(ja)
|
2015-12-08 |
2022-03-04 |
リンドラ セラピューティクス， インコーポレイティド |
胃滞留システムのための幾何学的構成
|
|
JP7132128B2
(ja)
*
|
2016-04-25 |
2022-09-06 |
ジェレシス，エルエルシー |
便秘の治療方法
|
|
BR112018072795A2
(pt)
|
2016-05-06 |
2019-04-30 |
Physician's Seal, LLC |
composição de valeriana e métodos relacionados
|
|
CA3025650A1
(en)
|
2016-05-27 |
2017-11-30 |
Lyndra, Inc. |
Materials architecture for gastric residence systems
|
|
JP6780412B2
(ja)
*
|
2016-09-28 |
2020-11-04 |
ライオン株式会社 |
コーティング組成物ならびにコーティング製剤及びその製造方法
|
|
AU2017336154B2
(en)
|
2016-09-30 |
2023-11-09 |
Lyndra Therapeutics, Inc. |
Gastric residence systems for sustained delivery of adamantane-class drugs
|
|
US10940113B2
(en)
*
|
2017-02-24 |
2021-03-09 |
Medical And Pharmaceutical Industry Technology And Development Center |
Pharmaceutical composition for colon targeting, method for treating a colon-related disease using the same and preparation method thereof
|
|
CN110996906A
(zh)
*
|
2017-06-09 |
2020-04-10 |
林德拉有限公司 |
具有调节释放速度的膜的胃驻留系统
|
|
WO2019217601A1
(en)
*
|
2018-05-08 |
2019-11-14 |
Protz Jonathan M |
Methods and compositions for drug targeted delivery
|
|
US11839666B2
(en)
|
2020-10-19 |
2023-12-12 |
The Procter & Gamble Company |
Oral care article comprising a hydrophobic delivery carrier and solid hydrophilic particles comprising an agent
|
|
CN114224860B
(zh)
*
|
2021-11-06 |
2023-04-28 |
山东润德生物科技有限公司 |
氨基葡萄糖钙片制剂及其制备方法与应用
|